JP Morgan Chase & Co’s Sonnet BioTherapeutics SONN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$34.5K Buy
2024
Q1
Sell
2023
Q4
$33 Buy
2023
Q3
Sell
2023
Q2
$14.7K Buy
2022
Q2
Sell
2022
Q1
$5K Buy
2020
Q4
Hold
2020
Q3
Hold
2020
Q2
Hold
2016
Q1
Hold
2015
Q4
Hold